Literature DB >> 1901695

Transferable imipenem resistance in Pseudomonas aeruginosa.

M Watanabe1, S Iyobe, M Inoue, S Mitsuhashi.   

Abstract

We isolated an imipenem-resistant strain, GN17203, of Pseudomonas aeruginosa. The strain produced a beta-lactamase that hydrolyzed imipenem. The beta-lactamase was encoded by a 31-MDa plasmid, pMS350, which belongs to incompatibility group P-9. The plasmic conferred resistance to beta-lactams, gentamicin, and sulfonamide and was transferable by conjugation to P. aeruginosa but not to Escherichia coli. The molecular weight of the purified enzyme was estimated to be 28,000, and the isoelectric point was 9.0. The enzyme showed a broad substrate profile, hydrolyzing imipenem, oxyiminocephalosporins, 7-methoxycephalosporins, and penicillins. The enzyme activity was inhibited by EDTA, iodine, p-chloromercuribenzoate, CuSO4, and HgCl2 but not by clavulanic acid or sulbactam.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901695      PMCID: PMC244956          DOI: 10.1128/AAC.35.1.147

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Characterization of beta-lactamases.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

Review 5.  Methodology for the study of beta-lactamases.

Authors:  K Bush; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

6.  Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa.

Authors:  J Trias; J Dufresne; R C Levesque; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

7.  In vitro activity of amifloxacin against outer membrane mutants of the family Enterobacteriaceae and frequency of spontaneous resistance.

Authors:  M Watanabe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.

Authors:  M Hiraoka; S Masuyoshi; S Mitsuhashi; K Tomatsu; M Inoue
Journal:  J Antibiot (Tokyo)       Date:  1988-01       Impact factor: 2.649

9.  Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.

Authors:  G J Cuchural; M H Malamy; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  Biochemical properties of beta-lactamase produced by Legionella gormanii.

Authors:  T Fujii; K Sato; K Miyata; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

View more
  166 in total

1.  Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Authors:  H Yano; A Kuga; R Okamoto; H Kitasato; T Kobayashi; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

3.  What's New in beta-lactamases?

Authors:  Patricia A. Bradford
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

4.  Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.

Authors:  I C Materon; T Palzkill
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

5.  Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an alcaligenes xylosoxidans strain.

Authors:  Shizuko Iyobe; Haruko Kusadokoro; Ayako Takahashi; Sachie Yomoda; Toyoji Okubo; Akio Nakamura; Koji O'Hara
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa.

Authors:  F Danel; L M Hall; B Duke; D Gur; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 7.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

8.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

9.  Class 1 integron containing metallo-beta-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan.

Authors:  Jun Yatsuyanagi; Shioko Saito; Seizaburo Harata; Noriyuki Suzuki; Yuko Ito; Ken-Ichi Amano; Katsuhiko Enomoto
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

10.  Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621.

Authors:  Gisela Santella; Simona Pollini; Jean-Denis Docquier; Ana Irina Mereuta; Gabriel Gutkind; Gian Maria Rossolini; Marcela Radice
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.